{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T01:06:50Z","timestamp":1792026410579,"version":"4.4.0"},"reference-count":10,"publisher":"Japan Endocrine Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1507\/endocrj.ej25-0150","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T22:07:18Z","timestamp":1761343638000},"page":"87-92","source":"Crossref","is-referenced-by-count":5,"title":["A case of prolonged adrenal insufficiency following osilodrostat discontinuation with a review of the literature"],"prefix":"10.1507","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6894-8648","authenticated-orcid":false,"given":"Sonia","family":"Kaniuka-Jakubowska","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Internal Medicine, Faculty of Medicine, Medical University of Gdansk, Gdansk 80-214, Poland"},{"name":"Department of Endocrinology and Internal Medicine, University Clinical Centre (UCK), Gdansk 80-952, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9529-2381","authenticated-orcid":false,"given":"Micha\u0142","family":"Kunc","sequence":"additional","affiliation":[{"name":"Department of Pathomorphology, Faculty of Medicine, Medical University of Gdansk, Gdansk 80-214, Poland"},{"name":"Department of Pathomorphology, University Clinical Centre (UCK), Gdansk 80-952, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6806-6079","authenticated-orcid":false,"given":"Maria","family":"Maksymowicz","sequence":"additional","affiliation":[{"name":"Department of Cancer Pathomorphology, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw 02-781, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-7767-8667","authenticated-orcid":false,"given":"Mariusz","family":"\u0141api\u0144ski","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, University Clinical Centre (UCK), Gdansk 80-952, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0363-6261","authenticated-orcid":false,"given":"Anna","family":"Kowalczyk","sequence":"additional","affiliation":[{"name":"Department of Oncology and Radiotherapy, Faculty of Medicine, Medical University of Gdansk, Gdansk 80-214, Poland"},{"name":"Department of Oncology and Radiotherapy, University Clinical Centre (UCK), Gdansk 80-952, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9663-2755","authenticated-orcid":false,"given":"Przemys\u0142aw","family":"K\u0142osowski","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Internal Medicine, Faculty of Medicine, Medical University of Gdansk, Gdansk 80-214, Poland"},{"name":"Department of Endocrinology and Internal Medicine, University Clinical Centre (UCK), Gdansk 80-952, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3897-5519","authenticated-orcid":false,"given":"Micha\u0142","family":"Szulc","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Internal Medicine, Faculty of Medicine, Medical University of Gdansk, Gdansk 80-214, Poland"},{"name":"Department of Endocrinology and Internal Medicine, University Clinical Centre (UCK), Gdansk 80-952, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John AH","family":"Wass","sequence":"additional","affiliation":[{"name":"Department of Endocrinology at the Oxford Centre for Diabetes, Endocrinology and Metabolism, Oxford University Hospitals NHS Foundation Trust, Oxford OX3 7LE, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4633-2863","authenticated-orcid":false,"given":"Renata","family":"\u015awi\u0105tkowska-Stodulska","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Internal Medicine, Faculty of Medicine, Medical University of Gdansk, Gdansk 80-214, Poland"},{"name":"Department of Endocrinology and Internal Medicine, University Clinical Centre (UCK), Gdansk 80-952, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Fleseriu M, Newell-Price J, Pivonello R, Shimatsu A, Auchus RJ, et al. (2022) Long-term outcomes of osilodrostat in Cushing\u2019s disease: LINC 3 study extension. Eur J Endocrinol 187: 531\u2013541.","DOI":"10.1530\/EJE-22-0317"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Gadelha M, Bex M, Feelders RA, Heaney AP, Auchus RJ, et al. (2022) Randomized trial of osilodrostat for the treatment of Cushing disease. J Clin Endocrinol Metab 107: e2882\u2013e2895.","DOI":"10.1210\/clinem\/dgac178"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Fleseriu M, Auchus RJ, Huang W, Spencer-Segal JL, Yuen KCJ, et al. (2025) Osilodrostat treatment of Cushing syndrome in real-world clinical practice: findings from the ILLUSTRATE study. J Endocr Soc 9: bvaf046.","DOI":"10.1210\/jendso\/bvaf046"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Yuen KCJ (2021) Osilodrostat: a review of recent clinical studies and practical recommendations for its use in the treatment of Cushing disease. Endocr Pract 27: 956\u2013965.","DOI":"10.1016\/j.eprac.2021.06.012"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Pivonello R, Simeoli C, Di Paola N, Larocca A, Crescenzo EM, et al. (2024) Osilodrostat: a novel potent inhibitor of 11-beta-hydroxylase for the treatment of Cushing\u2019s syndrome. touchREV Endocrinol 20: 43\u201351.","DOI":"10.17925\/EE.2024.20.1.8"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Tejani S, Abramowitz J, Tritos NA, Hamidi O, Mirfakhraee S (2024) Prolonged adrenal insufficiency after osilodrostat exposure with eventual recovery of adrenal function. JCEM Case Rep 2: luae088.","DOI":"10.1210\/jcemcr\/luae088"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Ferriere A, Salenave S, Puerto M, Young J, Tabarin A (2024) Prolonged adrenal insufficiency following discontinuation of osilodrostat treatment for intense hypercortisolism. Eur J Endocrinol 190: L1\u2013L3.","DOI":"10.1093\/ejendo\/lvad167"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Poirier J, Bonnet-Serrano F, Thomeret L, Bouys L, Bertherat J (2023) Prolonged adrenocortical blockade following discontinuation of Osilodrostat. Eur J Endocrinol 188: K29\u2013K32.","DOI":"10.1093\/ejendo\/lvad060"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9 Berruti A, Terzolo M, Pia A, Angeli A, Dogliotti L (1998) Mitotane associated with etoposide, doxorubicin, and cisplatin in the treatment of advanced adrenocortical carcinoma. Italian Group for the Study of Adrenal Cancer. Cancer 83: 2194\u20132200.","DOI":"10.1002\/(SICI)1097-0142(19981115)83:10<2194::AID-CNCR19>3.3.CO;2-V"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Sawabe F, Hayafusa R, Kosugi R, Ariyasu H (2024) A case of an ectopic ACTH-producing tumor with adrenal shrinkage during osilodrostat administration. JCEM Case Rep 2: luae008.","DOI":"10.1210\/jcemcr\/luae008"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/73\/1\/73_EJ25-0150\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T03:41:39Z","timestamp":1768016499000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/73\/1\/73_EJ25-0150\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej25-0150","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"EJ25-0150"}}